Sarah Venn gets shoot yourself in the foot award as review shows Seroxat is NOT worst drug

The Seroxat Users Group was unhappy about the conflict of interest on the review  team and its apparent reluctance to look at evidence of the side-effects suffered by its 4,000 members. Sarah Venn, of the group, said: "I think it is a decision that had to be made. The review members that they had were put in an untenable position faced with personal conflicts.




"But we definitely want the review to take place. The most important thing we want them to do is take account of the patient experiences, which the review has not yet agreed to do. We got as far as an agreement that they would meet with us."